Literature DB >> 33359734

Neurofilament light plasma concentration positively associates with age and negatively associates with weight and height in the dog.

Jackie Perino1, Margaret Patterson1, Mehdi Momen1, Mina Borisova2, Amanda Heslegrave2, Henrik Zetterberg3, Jordan Gruel1, Emily Binversie1, Lauren Baker1, John Svaren4, Susannah J Sample5.   

Abstract

Plasma neurofilament light chain (pNfL) concentration is a biomarker for neuroaxonal injury and degeneration and can be used to monitor response to treatment. Spontaneous canine neurodegenerative diseases are a valuable comparative resource for understanding similar human conditions and as large animal treatment models. The features of pNfL concentration in healthy dogs is not well established. We present data reporting basic pNfL concentration trends in the Labrador Retriever breed. Fifty-five Labrador Retrievers were enrolled. pNfL concentration was measured and correlated to age, sex, neuter status, height, weight, body mass index, and coat color. We found increased pNfL with age (P < 0.0001), shorter stature (P = 0.009) and decreased body weight (P < 0.001). These are similar to findings reported in humans. pNfL concentration did not correlate with sex, BMI or coat color. This data further supports findings that pNfL increase with age in a canine population but highlights a need to consider weight and height when determining normal pNfL concentration in canine populations.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dog; Light Chain; Neurofilament; Neuropathy

Mesh:

Substances:

Year:  2020        PMID: 33359734      PMCID: PMC7832257          DOI: 10.1016/j.neulet.2020.135593

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.

Authors:  Bob Olsson; Erik Portelius; Nicholas C Cullen; Åsa Sandelius; Henrik Zetterberg; Ulf Andreasson; Kina Höglund; David J Irwin; Murray Grossman; Daniel Weintraub; Alice Chen-Plotkin; David Wolk; Leo McCluskey; Lauren Elman; Leslie M Shaw; Jon B Toledo; Jennifer McBride; Pilar Hernandez-Con; Virginia M-Y Lee; John Q Trojanowski; Kaj Blennow
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

2.  Prediabetes, diabetes, metabolic syndrome, and small fiber neuropathy.

Authors:  Pariwat Thaisetthawatkul; Elizabeth Lyden; J Americo Fernandes; David N Herrmann
Journal:  Muscle Nerve       Date:  2020-02-18       Impact factor: 3.217

3.  Incidence of intervertebral disk degeneration-related diseases and associated mortality rates in dogs.

Authors:  Niklas Bergknut; Agneta Egenvall; Ragnvi Hagman; Pia Gustås; Herman A W Hazewinkel; Björn P Meij; Anne-Sofie Lagerstedt
Journal:  J Am Vet Med Assoc       Date:  2012-06-01       Impact factor: 1.936

4.  Body mass index predicts cognitive aging trajectories selectively for females: Evidence from the Victoria Longitudinal Study.

Authors:  Linzy Bohn; G Peggy McFall; Sandra A Wiebe; Roger A Dixon
Journal:  Neuropsychology       Date:  2020-01-30       Impact factor: 3.295

5.  Plasma Neurofilament Light Chain as a Translational Biomarker of Aging and Neurodegeneration in Dogs.

Authors:  Wojciech K Panek; Margaret E Gruen; David M Murdoch; Robert D Marek; Alexandra F Stachel; Freya M Mowat; Korinn E Saker; Natasha J Olby
Journal:  Mol Neurobiol       Date:  2020-05-30       Impact factor: 5.590

6.  Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.

Authors:  Federico Verde; Petra Steinacker; Jochen H Weishaupt; Jan Kassubek; Patrick Oeckl; Steffen Halbgebauer; Hayrettin Tumani; Christine A F von Arnim; Johannes Dorst; Emily Feneberg; Benjamin Mayer; Hans-Peter Müller; Martin Gorges; Angela Rosenbohm; Alexander E Volk; Vincenzo Silani; Albert C Ludolph; Markus Otto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-11       Impact factor: 10.154

7.  Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer's disease.

Authors:  Lars Nyberg; Anders Lundquist; Annelie Nordin Adolfsson; Micael Andersson; Henrik Zetterberg; Kaj Blennow; Rolf Adolfsson
Journal:  Alzheimers Dement (Amst)       Date:  2020-06-23

8.  Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles.

Authors:  Ashvini Keshavan; Amanda Heslegrave; Henrik Zetterberg; Jonathan M Schott
Journal:  Alzheimers Dement (Amst)       Date:  2018-07-02

9.  Neurofilament light is a treatment-responsive biomarker in CLN2 disease.

Authors:  Yuanbin Ru; Carley Corado; Russell K Soon; Andrew C Melton; Adam Harris; Guoying K Yu; Nancy Pryer; John R Sinclair; Martin L Katz; Temitayo Ajayi; David Jacoby; Chris B Russell; Sanjay Chandriani
Journal:  Ann Clin Transl Neurol       Date:  2019-12-08       Impact factor: 4.511

10.  Labrador retrievers under primary veterinary care in the UK: demography, mortality and disorders.

Authors:  Paul D McGreevy; Bethany J Wilson; Caroline S Mansfield; Dave C Brodbelt; David B Church; Navneet Dhand; Ricardo J Soares Magalhães; Dan G O'Neill
Journal:  Canine Genet Epidemiol       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.